Efficacy and safety of poly|D

Efficacy and safety of poly-D,L-lactic acid microspheres as ...

PDLLA microspheres were not inferior to HA, and 30 subjects completed the 24-month long-term safety evaluation follow up, which showed that ...

Poly-de-prescribing to treat polypharmacy: efficacy and safety

This self-selected sample longitudinal research strongly suggests that the negative, usually invisible effects of polypharmacy are ...

(PDF) Efficacy and safety of poly-D,L-lactic acid microspheres as ...

... No abnormal finding was found at the injection site. Animal studies proved the efficacy and safety of PDLLA microspheres as subdermal ...

Poly-de-prescribing to treat polypharmacy: efficacy and safety - PMC

Multiple morbidities lead to an increased number of drugs prescribed (polypharmacy) thus increasing the risk of adverse drug events (ADEs). De- ...

Efficacy and Safety of Poly-l-Lactic Acid in Facial Aesthetics - MDPI

The primary findings of this systematic review indicate that PLLA is a highly effective and long-lasting treatment for facial aesthetics. Its effectiveness ...

Efficacy and Safety of Crisugabalin (HSK16149) in Adults with ...

Reduced pain intensity is an important indicator of the effectiveness of PHN treatment. Crisugabalin, 40 mg/d, and crisugabalin, 80 mg/d, ...

Efficacy and Safety of High-Dose Vitamin D Supplementation vs ...

Results: Participants had a median age of 82.0 months and their baseline mean vitamin D level was 22.64 ng/mL. The VDS + SU group showed greater ...

Efficacy and Safety of Vamorolone Over 48 Weeks in Boys With ...

Gloss D, Moxley RT, Ashwal S, Oskoui M. Practice guideline update summary: corticosteroid treatment of Duchenne muscular dystrophy. Neurology. 2016;86(5):465- ...

Efficacy and Safety of Befotertinib (D-0316) in Patients With EGFR ...

Conclusions. Befotertinib of 75 to 100 mg has satisfying efficacy and manageable toxicity in patients with locally advanced or metastatic NSCLC ...

Efficacy and Safety of Daratumumab, Bortezomib ... - ASH Publications

After a median follow-up of 47.0 mo, progression-free survival (PFS) was significantly prolonged with D-Vd vs Vd in the ITT population (median: ...

Efficacy and safety of D. pteronyssinus immunotherapy in local ...

Immunotherapy was well tolerated; no systemic reactions were reported. This study demonstrated that AIT-DP is a safe and clinically effective ...

Efficacy and Safety of Vitamin D Supplementation to Prevent COVID ...

The results of our double-blind, placebo-controlled, prospective study demonstrate that VD supplementation is effective in preventing SARS-CoV-2 infection in ...

Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 ...

Healthy participants aged at least 12 years were enrolled and randomly assigned (1:1) to receive either ZyCov-D vaccine (Cadila Healthcare; 2 mg ...

Efficacy and Safety of Tocilizumab for the Treatment of Systemic ...

Time to treatment failure is supportive of a clinical benefit of TCZ in SSc. References: 1. Khanna D et al. Lancet. 2016;387:2630-2640. 2. Khanna D et al. Ann ...

Efficacy and Safety of Acoramidis in Transthyretin Amyloid ...

D., and Jing Du, M.D., of Eidos Therapeutics, a BridgeBio company, for providing support in the conduct of sensitivity analyses and in the ...

Efficacy and safety of first-line durvalumab (D) ± tremelimumab (T ...

Conclusions. Durvalumab resulted in a favourable HR for OS compared to CT in patients with PD-L1 TC≥25% in the Asian subpopulation, which was consistent with ...

Efficacy and safety of D-penicillamine, trientine, and zinc in pediatric ...

Wilson disease (WD) is a rare genetic disease affecting copper metabolism and the biliary tract's copper excretion.

Safety and Efficacy of SDX/d-MPH in Pediatric ADHD

First, it's a methylphenidate, it's a dextromethylphenidate, so this is going to be good for pretty much all children and adults who have ADHD [ ...

693 - Efficacy and safety of orismilast, a potent PDE4B/D inhibitor, in ...

Orismilast is a potent selective phosphodiesterase 4 (PDE4)-B and -D inhibitor, showing significant efficacy in a Phase 2b psoriasis study.

results from a phase 3, randomised, double-blind withdrawal trial

Efficacy and safety of tocilizumab in patients with polyarticular-course ... (D) Time to JIA-ACR30 flare after randomisation in the withdrawal phase ...